TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06400381

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: There are many mindfulness-based interventions protocol that can be implemented and practice by healthcare organization. In the current study, the intervention protocol the investigators will use is based on Smiths version of mindfulness meditation (Smith, 2005). This version is compromised of several components includes being mindful of breathing, thought, sounds, taste, body scan, and sitting. The initial educational session by power point presentation will be given to the participant to explain the intervention rationale and procedure of mindfulness in daily life. In addition to giving opportunity for the participant to ask questions during the educational session.
Study: NCT05479357

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: 10 iu will be given intravenously.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carbetocin
Description: 100 micrograms will be given intravenously.
Study: NCT05974124

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Povidone-Iodine 0.66%
Description: Povidone-iodine 0.66% eye drops were instilled 4 times daily for 3 days before cataract surgery in the eye to be operated on. The contralateral eye was considered as control and received no treatment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.02%
Description: Chlorhexidine 0.02% eye drops were instilled 4 times daily for 3 days before cataract surgery in the eye to be operated on. The contralateral eye was considered as control and received no treatment.
Study: NCT04675632

Intervention type: PROCEDURE
Intervention: Endovascular Therapy
Description: the most commonly used surgical options include: ordinary balloon dilatation， drug-coated balloon (DCB) dilatation and bare stent implantation.
Study: NCT06208280

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: After preconditioning with Fludarabine and Cyclophosphamide, F01 will be evaluated.
Description: Drug: After preconditioning with Fludarabine and Cyclophosphamide, F01 will be evaluated.~Biological: 0.5-3×10\^9 CAR+NK Cells, Treatment follows a lymphodepletion Drug: Fludarabine: 25-30 mg/m\^2 (D-5\~D-3) Drug: Cyclophosphamide: 250-300 mg/ m\^2 (D-5\~D-3)
Study: NCT06232824

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation
Description: The whole program is constituted of preoperative education and postoperative rehabilitation (in hospital and out of hospital). All the participants received the same preoperative education through the mobile phone application and oral communication. Participants in the intervention group get the multicomponent supervised tele-rehabilitation, while participants in the control group get the home-based self-rehabilitation. All the postoperative rehabilitation programs are presented and executed through the mobile phone application.
Study: NCT05357248

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BT-NCBT-00X
Description: the intervention group will consist of 20 patients to receive the BT-NCBT-00X treatment for 90 days. They will receive a baseline MRI-PDFF, Fibroscan and have the tests repeated at 90 days.
Study: NCT04978298

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rasigiline
Description: Rasigiline

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenelzine
Description: Phenelzine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozanimod
Description: Ozanimod

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozanimod
Description: Ozanimod
Study: NCT04945928

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Participants having been evaluated as operable after receiving first-line treatment (first-line chemotherapy, targeted therapy, immunotherapy, chemotherapy combined with immunotherapy, etc.) will receive surgery.
Study: NCT05681767

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational multicomponent lifestyle intervention + Treatment as usual
Description: Study intervention and treatment as usual~The study intervention is a multicomponent lifestyle intervention that targets exercise, diet, and stress management, and is conducted by motivational interviewing. The study nurse provides the study intervention. The intervention is conducted by motivational interviewing and includes the key elements of lifestyle interventions identified as effective (assessment of behavior at the baseline, giving information and advising, individualized goal setting, setting an action plan, monitoring a behavioral change, and giving feedback).~The intervention consists of individual appointments (2 x 45-60 min) and a telephone session ( 2 x 15 min) for three months. The participants receive a short educational guide (A4) on the lifestyle behavior recommendations.

Intervention type: OTHER
Group type: OTHER
Intervention: Treatment as usual
Description: Treatment as usual
Study: NCT00642083

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Viabahn stent-graft
Description: The viabahn stent-graft is a combined ePTFE-Nitinol self-expanding stent-graft preloaded on a catheter-based delivery system. It was originally designed for improving blood flow in patients with symptomatic peripheral arterial disease in superficial femoral artery lesions with reference vessel diameters ranging from 4.8 to 7.5 mm. This device is also increasingly used for the exclusion of popliteal aneurysms. Its flexibility might make the device ideal for the treatment of recurrent outflow stenosis in AV loop-fistula.
Study: NCT06522490

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual discrete trial training
Description: VDT was given to Experimental group.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual discrete trial training
Description: VDT was given to Experimental group.
Study: NCT06450483

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auricular vagus nerve stimulation
Description: Auricular vagal nerve stimulation using TPN dual channel TENS will be used for the study.The device used to stimulate is a conventional TENS. The stimulation is by applying a clip electrode placed on the tragus of the left ear and a second electrode applied on the left upper trapezius of the participant which will then stimulate the vagus nerve.Auricular vagus nerve stimulation session will be applied for 15 minutes. Participant is seated and relaxed.After the first session ended; heart rate will be measured and recorded once again to see the effect of the VNS.~Before the last AVNS session started; heart rate will be measured and recorded. The participants' vagus nerve is then stimulated for 15 minutes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auricular vagus nerve stimulation
Description: Auricular vagal nerve stimulation using TPN dual channel TENS will be used for the study.The device used to stimulate is a conventional TENS. The stimulation is by applying a clip electrode placed on the tragus of the left ear and a second electrode applied on the left upper trapezius of the participant which will then stimulate the vagus nerve.Auricular vagus nerve stimulation session will be applied for 15 minutes. Participant is seated and relaxed.After the first session ended; heart rate will be measured and recorded once again to see the effect of the VNS.~Before the last AVNS session started; heart rate will be measured and recorded. The participants' vagus nerve is then stimulated for 15 minutes.
Study: NCT04103749

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exalt Model D Single-Use Duodenoscope
Description: Subjects will have a clinically indicated per standard of care ERCP or other duodenoscope-based procedure performed with the Exalt single use duodenoscope study device.
Study: NCT05619172

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nanrilkefusp alfa
Description: Subcutaneous (SC) injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Intravenous (IV) infusion via peripheral or central venous line
Study: NCT06259370

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vigorous intermittent lifestyle physical activity
Description: The specific exercise regimen involves performing rope jumping activities three times a day, with each session aimed at surpassing the exercise threshold (not conducted in a continuous manner), where the heart rate should exceed 160 beats per minute. This routine will be undertaken five times a week, continuously for a span of 8 weeks.
Study: NCT06198582

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exercises
Description: In addition to conventional treatment, patients in the study group underwent a virtual reality-based task-specific exercise program in a computer-based virtual reality station. Two different virtual reality games that fit the definition of task-specific exercise were selected for our study. In order for the patient to complete the task in the game, the patient was asked to extend the upper extremity and hand to touch the virtual object through the reflection on the screen and to first grasp the object in the virtual environment by making active flexion with all fingers and to move it from one place to another on a certain plane without disturbing the grasping posture of the hand. These virtual reality exercises selected in our study were practiced under the supervision of the researcher 3 days a week for 15 minutes each for a total of 4 weeks. These sessions consisted of three sets of 2.5 minutes each for each game, with 15-second breaks between sets.
Study: NCT04988243

Intervention type: OTHER
Group type: OTHER
Intervention: All aortic valve products on the market
Description: 1. Subjects with severe aortic valve stenosis~2. Subjects who plan (or have) to use the transcatheter aortic valve replacement system for percutaneous aortic valve replacement~3. The patients agreed to join the study, voluntarily signed the informed consent and completed the follow-up;~4. Be able to contact the subjects or their legal guardians / relatives;~5. The medical record records the subjects who have died and can't get any contact information of the subjects（ (for dead cases only)~Sign the informed consent form, then check the inclusion and exclusion criteria, register after meeting the criteria, obtain the registration number, perform aortic valve replacement surgery, follow-up 24 hours, discharge, 30 days, 1 year, 2 years, 3 years, 4 years and 5 years after operation according to the test requirements, and carry out relevant follow-up according to the scheme requirements to collect data
Study: NCT06142929

Intervention type: PROCEDURE
Intervention: Microfasciectomy
Description: Using the microscope in Dupuytren's surgery

Intervention type: PROCEDURE
Intervention: Microfasciectomy
Description: Using the microscope in Dupuytren's surgery
Study: NCT04968769

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ischemic compression
Description: manual therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: kinesio taping
Description: elastic therapeutic taping

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: posture exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: posture exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: posture exercises
Study: NCT06521307

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside
Description: We will recruit the participant 24 hrs prior intervention, once the participant decides to enroll, we will administer by oral intake the supplement or placebo due to the result at randomizer.org.~The first NAD Riboside arm will be administered by oral intake with 2000 mg at enrollment, then we will administer 3000mg prior undergoing surgery with NG tube, 3000mg 12 hrs post-surgery with NG tube and 2000mg by oral intake 24 hrs after intervention. All the administrations with NG tube will be flushed with 0.9% saline solution.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: We will recruit the participant 24 hrs prior intervention, once the participant decides to enroll, we will administer by oral intake the supplement or placebo due to the result at randomizer.org.~The first dose of placebo arm will be administered by oral intake with 2000 mg at enrollment, then we will administer 3000mg prior undergoing surgery with NG tube, 3000mg 12 hrs post-surgery with NG tube and 2000mg by oral intake 24 hrs after intervention. All the administrations with NG tube will be flushed with 0.9% saline solution.
Study: NCT04607538

Intervention type: OTHER
Intervention: No intervention is made
Description: No intervention is made. This i an observational study.

Intervention type: OTHER
Intervention: No intervention is made
Description: No intervention is made. This i an observational study.

Intervention type: OTHER
Intervention: No intervention is made
Description: No intervention is made. This i an observational study.
Study: NCT05267522

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Egg diet
Description: 30% fat \[6% saturated fat\], 20% protein, 40% carbohydrate, 600 mg cholesterol

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Egg-free Diet
Description: 30% fat \[12% saturated fat\], 25% protein, 40% carbohydrate, 300 mg cholesterol

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Diet
Description: 30% fat \[12% saturated fat\], 25% protein, 40% carbohydrate, 600 mg cholesterol
Study: NCT05744817

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle strength training
Description: 30 breaths/day against a set resistance

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle strength training
Description: 30 breaths/day against a set resistance
Study: NCT04786717

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core muscle training
Description: The intervention of this group will focus on training the endurance of the core muscle.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: movement control training
Description: Based from the initial test, the subjects will receive either lumbar flexion control exercise or lumbar extension control exercise. They will perform each lumbar movement control exercise in different position. Starting from the lying position, then progressing to sitting, standing with support, and the last level will be standing without support. Each set of movement will be practiced 10 times, totally 10 sets. It will take approximately 5\~8 minutes to finish each movement. The subjects will learn 5\~8 types of the movement every week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: combined imagery and movement control training
Description: The intervention of this group is mostly same as the movement control training group. The different part is that the first 3 times of the movement will be practiced through image training, so the subjects will not have any real movement, and the last 7 times they will perform the lumbar motor control exercise literally. Each set of movement will be practiced 10 times, totally 10 sets. It will take approximately 5\~8 minutes to finish each movement. The subjects will learn 5\~8 types of the movement every week.
Study: NCT05737953

Intervention type: DIAGNOSTIC_TEST
Intervention: cfDNA methylation sequencing and proteome analysis
Description: Sequencing of cfDNA methylation and proteomic analysis of two sets of capsular fluid samples

Intervention type: DIAGNOSTIC_TEST
Intervention: cfDNA methylation sequencing and proteome analysis
Description: Sequencing of cfDNA methylation and proteomic analysis of two sets of capsular fluid samples
Study: NCT05777252

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Circuit Training
Description: Warm-up and cool-down protocols will be applied before and after each CT, and each exercise will be performed as 15 repetitions and an average of 40 seconds of rest will be given between exercises. Also, the intensity of CT will be determined according to the Borg scale (between 11 and 14). CT will include 'mini squat', 'step up', 'sit ups', 'reverse sit ups', 'leg press', 'leg curl', 'leg extension', 'crunches', 'lunge', 'prone bridge', and 'side bridge' exercises.
Study: NCT06093841

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Relmacabtagene Autoleucel
Description: A single infusion of chimeric antigen receptor (CAR)-transduced autologous T cells

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Administered according to package insert

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Administered according to package insert
Study: NCT05080335

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Short videos
Description: As an educational RCT, the didactic content will be the same across the four arms, but its deliver will vary by:~1. TRANS- vs CIS-gender female instructors~2. With or without short videos of transgender youth embedded into the didactic \[TV or CV\]; for the group with no embedded videos \[NV\], the same videos will be shown AFTER completion of the post measures)~3. No-intervention control, in which TV will be delivered \*after\* collection of pre/post measures.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Short videos
Description: As an educational RCT, the didactic content will be the same across the four arms, but its deliver will vary by:~1. TRANS- vs CIS-gender female instructors~2. With or without short videos of transgender youth embedded into the didactic \[TV or CV\]; for the group with no embedded videos \[NV\], the same videos will be shown AFTER completion of the post measures)~3. No-intervention control, in which TV will be delivered \*after\* collection of pre/post measures.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Short videos
Description: As an educational RCT, the didactic content will be the same across the four arms, but its deliver will vary by:~1. TRANS- vs CIS-gender female instructors~2. With or without short videos of transgender youth embedded into the didactic \[TV or CV\]; for the group with no embedded videos \[NV\], the same videos will be shown AFTER completion of the post measures)~3. No-intervention control, in which TV will be delivered \*after\* collection of pre/post measures.
Study: NCT05009004

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: text messages to support medication adherence
Description: text messages to support medication adherence
Study: NCT05318352

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Description: Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation technique that modulates cortical activity. tDCS has been conducted to improve wide range of neurological impairments including sleep.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation technique that modulates cortical activity. tDCS has been conducted to improve wide range of neurological impairments including sleep.
Study: NCT05360680

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CUE-102
Description: CUE-102 is a novel fusion protein developed for the treatment of patients with WT1-positive malignancies.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CUE-102
Description: CUE-102 is a novel fusion protein developed for the treatment of patients with WT1-positive malignancies.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CUE-102
Description: CUE-102 is a novel fusion protein developed for the treatment of patients with WT1-positive malignancies.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CUE-102
Description: CUE-102 is a novel fusion protein developed for the treatment of patients with WT1-positive malignancies.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CUE-102
Description: CUE-102 is a novel fusion protein developed for the treatment of patients with WT1-positive malignancies.
Study: NCT06344962

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Absorbable Suture
Description: 3-0 V-Loc

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-absorbable Suture
Description: 3-0 Prolene
Study: NCT00760032

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Description: Ciprofloxacin oral, 500 mg capsules, one capsule per day during four weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules, one capsule per day during four weeks.
Study: NCT06045156

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tirofiban
Description: Tirofiban is a selective glycoproteinⅡb/Ⅲa receptor inhibitor, which inhibits platelet aggregation and thrombi formation

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tirofiban simulant
Description: Tirofiban simulant is placebo packed the same style as tirofiban
Study: NCT05740540

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IRS-8
Description: Implanted Receiver Stimulator (IRS) delivering 8 channels of stimulation. Appropriate for muscle-based (intramuscular or epimysial) electrodes only

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IST 12 & IST 16
Description: Implantable Stimulator Telemeter (IST) that provides 12 independent channels of stimulation with the option of 2 channels of bipolar myoelectric signal recording, or 16 independent stimulus channels. Suitable for muscle-based or nerve cuff electrodes such as the CWRU Spiral, Flat Interface Nerve Electrode (FINE) or Composite-Flat Interface Nerve Electrode (C-FINE).
Study: NCT05824104

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxia
Description: The intermittent hypoxia protocol refers to four cycles of 5 minutes hypoxia inhaling interval by 5 minutes normoxia, which is performed twice a day (at least 6 hours apart) in 7 days.
Study: NCT04569487

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy
Description: Muscle biopsy from vastus lateralis (100-200 mg from non-dominant leg)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy
Description: Muscle biopsy from vastus lateralis (100-200 mg from non-dominant leg)
Study: NCT04617704

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GC012F injection
Description: GC012F injection is a autologous dual CAR-T targeted BCMA and CD19. A single infusion of CAR-T cells will be administered intravenously.